Fluconazole for Refractory Oropharyngeal Candidiasis in AIDS Patients
| Autor: | Daniel Reich, Ana Espinel-Ingroff, Arthur M. Quart |
|---|---|
| Rok vydání: | 1995 |
| Předmět: |
education.field_of_study
medicine.medical_specialty Leadership and Management Clotrimazole Itraconazole business.industry Population Public Health Environmental and Occupational Health medicine.disease Dermatology Oropharyngeal Candidiasis Surgery Acquired immunodeficiency syndrome (AIDS) Refractory Weight loss medicine medicine.symptom education business Fluconazole medicine.drug |
| Zdroj: | AIDS Patient Care. 9:56-59 |
| ISSN: | 0893-5068 |
| DOI: | 10.1089/apc.1995.9.56 |
| Popis: | Oropharyngeal candidiasis is a major lesion in HIV-infected patients. Effective antifungal therapy is required to prevent weight loss, nutritional compromise, and systemic infection. The response to oral fluconazole in patients refractory to prior topical or systemic antifungal therapy was evaluated. A case of oropharyngeal candidiasis in a patient with advanced AIDS that was refractory to topical clotrimazole and oral itraconazole, but responded to oral fluconazole therapy, is reported. Oral fluconazole should be considered the primary treatment for oropharyngeal candidiasis in the HIV-infected population with AIDS status. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|